NCT05414591View on ClinicalTrials.gov

Pharmacokinetics and Safety Following Administration of DWP16001

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions
Healthy
Interventions
DRUG

DWP16001 drug A

1 tablet, Oral, once daily single dose

DRUG

DWP16001 drug B

3 tablet, Oral, once daily single dose

Trial Locations (1)

13496

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05414591 - Pharmacokinetics and Safety Following Administration of DWP16001 | Biotech Hunter | Biotech Hunter